This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Sigma-Aldrich Co. LLC. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Qingzhou Ji: Innovator in Targeted Histone Acetylation
Introduction
Qingzhou Ji is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of molecular biology, particularly in the area of histone acetylation. His innovative work has implications for gene regulation and therapeutic applications.
Latest Patents
Qingzhou Ji holds a patent for "Targeted Histone Acetylation." This patent provides compositions and methods for acetylating histones at targeted chromosomal locations within a cell. The disclosure includes a fusion protein that comprises a DNA binding domain and at least one histone acetyltransferase (HAT) domain. The DNA binding domain is designed to target the fusion protein to specific chromosomal locations, while the HAT domain is responsible for acetylating histones at these targeted sites.
Career Highlights
Qingzhou Ji is currently employed at Sigma-Aldrich Co. LLC, a leading company in the life sciences sector. His work at Sigma-Aldrich has allowed him to further develop his research and contribute to advancements in biochemistry and molecular biology.
Collaborations
Some of his coworkers include Carol A Kreader and Carol Kreader. Their collaboration has likely fostered a productive research environment, enhancing the potential for innovative discoveries.
Conclusion
Qingzhou Ji's contributions to targeted histone acetylation represent a significant advancement in the field of molecular biology. His innovative approaches and collaborations continue to influence research and development in this important area.